Silacyclic Derivatives of Heteroaromatic Sulfides as Selective Cholesterol Level Lowering and Vasodilating Agents
2002

Silacyclic Derivatives of Heteroaromatic Sulfides for Lowering Cholesterol and Vasodilation

Sample size: 8 publication Evidence: moderate

Author Information

Author(s): Edgars Abele, Kira Rubina, Ramona Abele, Olegs Dzenitis, Pavel Arsenyan, Juris Popelis, Maris Veveris, Dainuvite Meirena, Edmunds Lukevics

Primary Institution: Latvian Institute of Organic Synthesis

Hypothesis

Can silacyclic derivatives of heteroaromatic sulfides selectively lower cholesterol levels and act as vasodilators?

Conclusion

The synthesized silacyclic derivatives effectively lowered LDL cholesterol levels and showed some vasodilating activity.

Supporting Evidence

  • Compounds showed high antiatherosclerotic activity.
  • Silacyclic derivatives were isolated in yields up to 70%.
  • Imidazole derivative showed a tendency to increase HDL levels.
  • Benzoxazole and triazole derivatives exhibited the highest activity.
  • Low acute toxicity was observed for most compounds.

Takeaway

Scientists made new compounds that can help lower bad cholesterol and might help with blood flow.

Methodology

The compounds were synthesized using a phase transfer catalytic system and their effects on cholesterol levels and vasodilation were tested in mice.

Limitations

The compounds exhibited weak vasodilating activity and some had low acute toxicity.

Participant Demographics

Mice with a high cholesterol diet were used for testing.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication